Clinical Trials
71 trialsan AI-Driven Four-Tier Invasion Depth Classification for Early Esophageal Cancer
Fudan University
A Prospective Study of Tumor-specific Tpex in Negative Lymph Nodes for Predicting Pathological Complete Response to Neoadjuvant PD 1 Therapy in Esophageal Cancer
Fudan University
Infiltration Pattern of Locally Advanced ESCC
Shanghai Chest Hospital
Tpex Subsets in Negative Tumor Draining Lymph Nodes for Predicting the Efficacy of PD 1 Inhibitors in Advanced or Recurrent Esophageal Squamous Cell Carcinoma
Fudan University
METAGIO
Bristol-Myers Squibb
TME-ESCC
Nanjing Medical University
Real-world Experience of ICIs Plus Chemotherapy for Advanced ESCC.
Fudan University
SAPHIR
iOMEDICO AG
PKU-ESCC-EF
Peking University Cancer Hospital & Institute
FEO
Société Française d'Endoscopie Digestive
MASST
University Health Network, Toronto
SYNERGY
City of Hope Medical Center
MiGIC
City of Hope Medical Center
PPIO-005 The Relationship Between Different Nutritional Pathways and Tumor Outcomes After Minimally Invasive Esophagectomy
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
A Retrospective Cohort Study of Patients Who Underwent Curative-intent Esophagectomy for ESCC at a Tertiary Referral Center in South Korea
Samsung Medical Center
PPIO-007 Correlation Analysis of Type II Diabetes Mellitus on Short-term and Long-term Outcomes of Patients With Esophageal Squamous Cell Cancer Undergoing Minimally Invasive Esophagectomy
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
pCR-ESCC
Nanjing Medical University
PKU-ESCC
Peking University Cancer Hospital & Institute
PB-PD1R-SCC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
DL-ESCC
Tongji Hospital
An Observational Study on the Safety and Efficacy of Immunotherapy Combined With Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma
Three Gorges Hospital of Chongqing University
CT and Endoscopic Biopsy Image-Based Deep Learning for Predicting Left Recurrent Laryngeal Nerve Lymph Node Metastasis in Esophageal Cancer
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Predicting Postoperative Chemotherapy Efficacy in Patients With Esophageal Squamous Cell Carcinoma
City of Hope Medical Center
Diagnostic Accuracy of Endocytoscopy for Superficial Esophageal Neoplasia
Changhai Hospital
ViSON
Imperial College London
Prognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant Therapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
A Multicenter Cancer Biospecimen Collection Study
Cofactor Genomics, Inc.
preSINO
Shanghai Chest Hospital
MAGnET
Royal Marsden NHS Foundation Trust
Tumor Regression Grade As Predictor of Adjuvant Therapy
Fujian Medical University Union Hospital
Prediction of Lymph Node Status in Stage T1 Esophageal Squamous Cell Carcinoma（RENMIN-237）
Renmin Hospital of Wuhan University
Individualized Tumor-Informed CtDNA Analysis for Monitoring Postoperative Recurrence in ESCC (NEOCRTEC2401)
Sun Yat-sen University
SCHRT
Anhui Provincial Hospital
CMECC
Changhai Hospital
Accurate Diagnosis of the Invasion Depth in ESCC by a Deep Neural Network Analysis of NBI Endoscopy Data
RenJi Hospital
REICRAE
Tianjin Medical University Cancer Institute and Hospital
The Prognostic Value of Tertiary Lymphatic Structure in Esophageal Squamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital
Multi-institutional Analysis of Survival and Recurrence Patterns of Different Pathological Regression Types After Neoadjuvant Chemoradiotherapy or Radiotherapy for Esophageal Squamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital
Oral Microbiome is Associated With the Response to Chemoradiotherapy in Initial Inoperable Patients With Esophageal Squamous Cell Cancer
Anhui Provincial Hospital
Trajectory Analysis of NLR and Its Association With Efficacy of Immunochemotherapy in ESCC.
Guangdong Provincial People's Hospital
Whole-course Immunonutrition Combined With Chemoradiotherapy±ICIs for Local Advanced Patients With Inoperable Esophageal Squamous Cell Carcinoma
Anhui Provincial Hospital
ECPLNMvsSLNM
Sichuan Cancer Hospital and Research Institute
EC-CRT-005
Sun Yat-sen University
ctDNA
Hebei Medical University Fourth Hospital
Efficacy Evaluation and Recurrence Monitoring of Therapy for Esophageal Squamous Cell Carcinoma Based on ctDNA-MRD.
Guangdong Provincial People's Hospital
Neoadjuvant Anti-PD-1 Plus Chemotherapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital
An Exploratory Study of ctDNA-MRD in Predicting the Efficacy of Esophageal Squamous Cell Carcinoma
Guangzhou Institute of Respiratory Disease
To Compare the Effect of Different Nutritional Pathways on Improving Nutritional Status of Esophageal Cancer Patients Undergoing Chemoradiotherapy
Tianjin Medical University Cancer Institute and Hospital
The Microbiome of Oesophageal Squamous Cell Carcinoma
Chinese University of Hong Kong
HIV and Other Risk Factors for Esophageal Squamous Cell Carcinoma in Malawi
UNC Lineberger Comprehensive Cancer Center